EBOS Group Ltd (ASX: EBO) shares were trading at 18.62 AUD, down 1.38% or 0.26 during the afternoon trading session on 30 July 2026. The stock has also recorded a decline of 49.88% over the past year, representing a decrease of 18.53 during the …
PYC Therapeutics Ltd (ASX: PYC) shares moved higher on 30 July 2026, gaining 3.38% to AUD 1.68 after the biotechnology company released its Q2 2026 shareholder update. The update highlighted progress across the company’s precision medicine pipeline, including clinical trial advancement, regulatory milestones and …
Artrya Limited (ASX: AYA) shares declined 14.05% on 30 July 2026, to trade at $4.10 after the company released its June 2026 quarterly activities and cashflow report. The decline came despite the medical technology company reporting progress across customer adoption, product development and regulatory …
EchoIQ Ltd (ASX: EIQ) shares moved higher on 30 July 2026, rising 1.59% to AUD 1.28. The company released its quarterly activities report on 27 July. The update highlighted a series of strategic developments, including a proposed partnership with Pro Medicus, a major capital …
Neuren Pharmaceuticals Ltd (ASX: NEU) shares moved higher on 30 July 2026, rising 1.31% to AUD 17.36. The share movement followed continued investor interest after the company’s latest announcement on 24 July 2026 regarding progress in its Phase 3 clinical development program for NNZ-2591.
Telix Pharmaceuticals Ltd (ASX:TLX) traded at AUD 14.11 during the afternoon trading session on 30 July 2026, recording a decline of 2.69%, or AUD 0.39. The company’s shares remain down 31.77% over the past year, representing a decrease of AUD 6.57.
Anagenics Limited (ASX: AN1) attracted market attention after its share price increased16.67%toAUD 0.0070on 30 July 2026. The company released its latest quarterly activity report on the same day, outlining improved operational performance, progress following its restructuring program, and expectations of reporting its maiden full-year …
Careteq Limited (ASX: CTQ) shares remained unchanged atAUD 0.012on 30 July 2026 as investors assessed the company’s latest quarterly activities report outlining balance sheet improvements, strategic restructuring, and the next phase of its healthcare technology strategy. The company’s Q4 FY26 update highlighted significant changes …
EBR Systems, Inc. (ASX:EBR) remains focused on the commercial expansion of its wireless cardiac pacing technology as investors assess the company’s transition from clinical development toward revenue generation. Shares were trading at A$0.26 on 30 July 2026, representing a daily movement of 3.64%, with …
Epiminder Limited (ASX:EPI) released its FY26 and Q4 operational update, outlining progress across its DETECT reimbursement study, next-generation Minder® device development and commercialisation pathway for its epilepsy monitoring technology.